Home
Newsletter
Events
Blogs
Reports
Graphics
RSS
About Us
Contact Us
Write for Us
Media Info
Advertising Info
Prexige

Canada Bans Anti-Inflammatory Drug Prexige after Reports of Severe Liver Damage

Monday, March 03, 2008 by: David Gutierrez, staff writer
Tags: Prexige, health news, Natural News


Most Viewed Articles
https://www.naturalnews.com/022767_drug_Prexige_Canada.html
Delicious
diaspora
Print
Email
Share

(NaturalNews) Canada's government health agency, Health Canada, has announced the withdrawal of market authorization for non-steroidal anti-inflammatory lumiracoxib due to evidence connecting the drug to severe liver damage.

Health Canada requested that Novartis stop selling lumiracoxib, marketed as Prexige, and the company has complied with the request.

Prexige is used primarily to treat osteoarthritis patients, and has been approved for sale in 21 countries. The drug's troubles began in August when the Therapeutic Goods Administration of Australia withdrew its approval for Prexige after reviewing evidence on 8 reports of severe liver damage arising from use of the drug. This included two deaths and two liver transplants. Following Australia's decision, New Zealand also pulled the drug from the market.

According to Health Canada, there have been two confirmed cases of liver-related complications from Prexige in Canada. The agency reviewed additional safety information provided by Novartis, and concluded that "the risk of serious hepatotoxicity associated with the use of Prexige cannot be safely and effectively managed."

Health Canada advised all doctors and pharmacists to discontinue prescribing Prexige, return all samples, and discuss new treatment options with patients currently on the drug. It encouraged patients to return any supplies of the drug to their pharmacists. "In order to avoid contaminating ground or municipal water systems, the product should not be flushed down the toilet or sink," Health Canada said.

In 2003, the U.S. FDA rejected the trade name "Prexige" for lumiracoxib. The agency has not yet ruled on whether to approve the drug for use and sale in the United States. Likewise, it has not yet been revealed what trade name the drug would use if approved, although "Prexede" has been suggested.

Countries in which Prexige is still approved for use include Argentina, Brazil, Mexico, South Africa and all European Union countries.

Receive Our Free Email Newsletter

Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.


comments powered by Disqus


Natural News Wire (Sponsored Content)

Science.News
Science News & Studies
Medicine.News
Medicine News and Information
Food.News
Food News & Studies
Health.News
Health News & Studies
Herbs.News
Herbs News & Information
Pollution.News
Pollution News & Studies
Cancer.News
Cancer News & Studies
Climate.News
Climate News & Studies
Survival.News
Survival News & Information
Gear.News
Gear News & Information
Glitch.News
News covering technology, stocks, hackers, and more